ArticleScientific reports2026
Genomic investigation reveals local persistence and regional circulation of dengue virus associated with recent outbreaks in Kenya.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Tracking the clinico-microbiological profile and molecular characterization of dengue cases during the monsoon-season in Belagavi, Karnataka.PLoS neglected tropical diseases · 2026Observational
- Role of invasive Aedes (Aedimorphus) vittatus in chikungunya virus transmission in the newly-invaded coastal island city of Mombasa, Kenya.PLoS neglected tropical diseases · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
Abstract
Dengue is an arbovirus disease caused by dengue virus. The virus has recently caused a global surge in cases, with Africa reporting over 250 million and 900 deaths since 2023. This study was conducted during the 2023 dengue outbreak in Mombasa, with the aim of understanding outbreak cases in the context of earlier cases and recent global epidemics. During the 2023 outbreak, 56 of 406 samples tested positive for DENV: including DENV-1, DENV-2, and DENV-3. The study generated 38 whole genome sequences, 24 from 2023 to 14 from cases identified between 2020 and 2025. Phylogenetic analysis showed DENV-2 exhibited patterns suggesting long-term local circulation, while DENV-1 and DENV-3 were more widespread regionally, and are linked to recent outbreaks in Eastern and Western Africa. These findings highlight the need for integrated strategies to curb dengue in Kenya, such as measures to disrupt local transmission as well as importation of new strains.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.